Aehr Test Systems, Inc. AEHR R2KR3KAITECH
Company Overview
Aehr Test Systems, Inc. provides test solutions for testing, burn-in, and semiconductor devices at wafer level, singulated die, and package level in the United States, Asia, Europe, and the Middle East. The company offers FOX-XP and FOX-NP systems, which are full wafer contact and singulated die/module test and burn-in systems that test, burn-in, and stabilize a range of devices, including silicon carbide-based (SIC) and gallium nitride (GAN) power semiconductors; 2D and 3D sensors used in mobile phones, tablets, and other computing devices; memory semiconductors; processors; microcontrollers; systems-on-a-chip; and photonics and integrated optical devices used in AI. It also provides the FOX-CP system, a single-wafer compact test solution for logic, memory, and photonic devices; and the FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, the company offers the FOX DiePak Carrier, which allows testing, burn-in, and stabilization of singulated bare die and modules; FOX WaferPak Aligner; and FOX DiePak Loader. Further, it provides system installation and repair, applications engineering support, spare parts inventories, customer training, and documentation services. The company sells its products in the United States, Germany, Japan, the Philippines, and Taiwan through distributors and sales representatives. It serves semiconductor manufacturers, semiconductor contract assemblies, electronics manufacturers, and burn-in and test service companies. Aehr Test Systems, Inc. was incorporated in 1977 and is headquartered in Fremont, California.
Why Investors Should Care
Revenue has grown at a 10.2% CAGR over the past five years.
Recent Developments
- May 2026 Revenue of $50.00M (-15.2% YoY); net profit $-7.13M.
- Trailing 12 Months Year-on-year growth — revenue +33.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.18% |
| 1 Year: | 33.70% |
Stock Price Performance
| 1 Year: | +327.88% |
| 6 Months: | +142.24% |
| 3 Months: | -12.38% |
| 1 Month: | -13.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Aehr Test Systems makes wafer-level test and burn-in equipment used to qualify the power semiconductors and AI processors that need reliability screening.
FOX wafer-level test, burn-in and stabilisation systems for silicon-carbide power devices, processors and photonics — including emerging AI-processor burn-in.
- AI-processor burn-in Aehr is extending its wafer-level burn-in systems to test AI processors, which increasingly require reliability screening.
- Silicon-carbide test FOX systems test and stabilise silicon-carbide power devices used in EVs and power electronics.
- WaferPak/DiePak consumables Contactor consumables provide recurring revenue across the installed base.
- Niche test/burn-in supplier diversifying from silicon-carbide into AI-processor burn-in.
- Consumable contactors add recurring revenue.
- Revenue recently fell sharply (~-44%) and the company is loss-making — highly cyclical.
- Extreme customer concentration and a very high P/E on trough earnings are key risks.
Curated from public filings and analyst commentary; figures are illustrative.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 10.2% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 40.8% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AEHR Aehr Test Systems, Inc. R2KR3KAITECH | 86.26 | -375.04 | $2.81B | 0.00% | -6.18% | -4.16% | 10.18% | - |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 230.36 | 35.28 | $5.58T | 0.46% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 319.97 | 36.69 | $4.67T | 0.35% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 499.70 | 27.85 | $3.71T | 0.73% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 426.34 | 37.46 | $2.21T | 0.91% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 357.90 | 59.55 | $1.70T | 0.62% | 16.70% | 37.28% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,016.59 | 22.97 | $1.15T | 0.06% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 477.57 | 122.14 | $779.62B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,714.88 | 58.49 | $658.69B | 0.53% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Feb 2016 | May 2016 | Aug 2016 | Nov 2016 | Feb 2017 | May 2017 | Aug 2017 | Nov 2017 | Feb 2018 | May 2018 | Aug 2018 | Nov 2018 | Feb 2019 | May 2019 | Aug 2019 | Nov 2019 | Feb 2020 | May 2020 | Aug 2020 | Nov 2020 | Feb 2021 | May 2021 | Aug 2021 | Nov 2021 | Feb 2022 | May 2022 | Aug 2022 | Nov 2022 | Feb 2023 | Aug 2023 | Nov 2023 | Feb 2024 | Aug 2024 | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 6.97M | 7.92M | 7.39M | - | 4.74M | 5.91M | 3.16M | - | 5.53M | 6.87M | 6.11M | - | 2.01M | 1.68M | 5.27M | - | 5.65M | 9.61M | 15.28M | - | 10.67M | 14.81M | 17.21M | 20.62M | 21.43M | 7.56M | 13.12M | - | - | 14.09M | 10.97M | 9.88M | 10.31M | 18.84M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.82M | 7.25M | 7.34M | 6.95M | 10.82M |
| Gross Profit | 169.00K | -98.00K | 2.21M | 1.46M | 503.00K | 2.61M | 2.92M | 3.13M | 3.18M | 3.16M | 1.55M | 2.40M | 272.00K | 3.38M | 2.27M | 3.20M | 2.99M | -93.00K | 227.00K | 377.00K | 1.89M | 3.53M | 2.28M | 4.52M | 6.40M | 10.47M | 4.48M | 7.91M | 8.88M | 9.98M | 10.96M | 3.16M | 7.08M | - | - | 4.27M | 3.72M | 2.54M | 3.37M | 8.02M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.61M | 7.57M | 7.41M | 7.60M | 9.22M |
| Operating Income | -2.82M | - | -570.00K | -1.28M | -2.47M | - | 172.00K | 187.00K | 307.00K | - | -1.44M | -565.00K | -3.12M | - | -429.00K | 250.00K | 255.00K | - | -2.19M | -1.94M | -652.00K | - | -993.00K | 717.00K | 2.26M | - | 458.00K | 3.48M | 3.79M | 4.12M | 5.47M | -2.05M | 159.00K | - | - | -2.34M | -3.85M | -4.86M | -4.23M | -1.21M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.32M | -2.92M | -3.99M | -3.37M | -329.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.99M | -2.84M | -4.44M | -4.00M | -455.00K |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -87.00K | -752.00K | -1.21M | -798.00K | -1.85M |
| Net Income | -2.98M | -3.06M | -755.00K | -1.45M | -2.65M | -795.00K | 10.00K | 60.00K | 267.00K | 191.00K | -1.51M | -629.00K | -3.20M | 110.00K | -413.00K | 251.00K | 245.00K | -2.88M | 107.00K | -1.97M | -735.00K | 567.00K | 696.00K | 717.00K | 2.24M | 5.79M | 589.00K | 3.73M | 4.13M | 4.67M | 6.09M | -1.47M | 660.00K | - | - | -2.90M | -2.08M | -3.23M | -3.20M | 1.39M |
| Diluted EPS | -0.23 | - | -0.06 | -0.09 | -0.16 | - | 0.00 | 0.00 | 0.01 | - | -0.07 | -0.03 | -0.14 | - | -0.02 | 0.01 | 0.01 | - | 0.00 | -0.08 | -0.03 | - | 0.03 | 0.03 | 0.08 | 0.20 | 0.02 | 0.13 | 0.14 | 0.16 | 0.20 | -0.05 | 0.02 | - | - | -0.10 | -0.07 | -0.11 | -0.10 | 0.04 |
| R&D Expense | 1.29M | - | 1.06M | 1.04M | 1.25M | - | 955.00K | 1.09M | 1.04M | - | 1.12M | 986.00K | 931.00K | - | 892.00K | 795.00K | 845.00K | - | 900.00K | 820.00K | 903.00K | - | 1.32M | 1.31M | 1.53M | - | 1.50M | 1.55M | 1.83M | 2.46M | 1.97M | 2.14M | 2.36M | 2.28M | 3.14M | - | 2.85M | 2.97M | 3.17M | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | May 2017 | May 2018 | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.67M | 13.74M | 15.52M | 16.49M | 19.68M | 10.02M | 14.50M | 18.90M | 29.55M | 21.06M | 22.29M | 16.60M | - | 64.96M | 66.22M | 58.97M | 50.00M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.22M | 33.67M | 35.03M | 32.35M |
| Gross Profit | 6.10M | 5.51M | 6.21M | 6.78M | 10.22M | 3.84M | 5.14M | 6.78M | 12.39M | 7.60M | 8.37M | 6.03M | - | 32.75M | 32.54M | 23.93M | 17.65M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.37M | 22.46M | 28.75M | 31.79M |
| Operating Income | -756.00K | -4.19M | -4.51M | -3.31M | 497.00K | -6.69M | -6.15M | -4.93M | 915.00K | -5.00M | -2.77M | -4.18M | - | 13.38M | 10.08M | -4.81M | -14.14M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.47M | 11.44M | -1.43M | -10.61M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.62M | 12.46M | -4.29M | -11.74M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.00K | -20.70M | -381.00K | -4.61M |
| Net Income | -481.00K | -3.39M | -3.39M | -3.42M | 422.00K | -6.65M | -6.79M | -5.65M | 528.00K | -5.24M | -2.80M | -2.03M | - | 14.56M | 33.16M | -3.91M | -7.13M |
| Diluted EPS | -0.06 | -0.39 | -0.38 | -0.36 | 0.04 | -0.55 | -0.52 | -0.35 | 0.02 | -0.23 | -0.12 | -0.09 | 0.34 | 0.50 | 1.12 | - | - |
| R&D Expense | 4.76M | 4.57M | 4.19M | 3.21M | 3.40M | 4.06M | 4.32M | 4.66M | 4.18M | 4.15M | 3.39M | 3.65M | 5.82M | 7.13M | 8.72M | 10.46M | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | May 2009 | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | May 2017 | May 2018 | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 12.08M | 11.61M | 10.97M | 12.22M | 14.87M | 10.05M | 30.89M | 30.95M | 21.31M | 20.57M | 21.66M | - | 98.14M | 127.91M | 148.51M | 246.69M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 89.03M | 97.85M | 88.78M | 184.45M |
| Cash & Equivalents | 4.36M | 7.77M | 4.02M | 2.07M | 2.32M | 1.81M | 5.53M | 939.00K | 17.80M | 16.85M | 5.43M | 5.43M | 4.58M | - | 30.05M | 49.16M | 24.53M | 116.36M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.91M | 37.47M | 42.00M | 41.35M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.59M | 9.80M | 14.19M | 17.47M |
| Total Liabilities | - | - | 2.98M | 5.16M | 5.98M | 5.20M | 10.32M | 10.77M | 14.10M | 11.67M | 5.85M | 6.52M | 10.22M | - | 22.54M | 16.32M | 25.64M | 27.18M |
| Current Liabilities | - | - | 2.54M | 4.81M | 5.70M | 5.12M | 6.52M | 4.68M | 7.88M | 11.15M | 5.51M | 3.87M | 9.06M | - | 16.31M | 10.51M | 15.64M | 17.86M |
| Long Term Debt | - | - | - | - | - | 0 | 3.79M | 5.96M | 6.11M | 0 | 0 | 1.03M | 0 | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.30M | 6.20M | 10.83M | 9.88M |
| Total Equity | 9.96M | 11.28M | 9.10M | 6.48M | 5.01M | 7.05M | 4.57M | -703.00K | 16.81M | 19.30M | 15.47M | 14.06M | 11.45M | - | 75.60M | 111.59M | 122.87M | 219.51M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 28.54M | 29.00M | 29.88M | 32.48M |
Cash Flows (Annual)
Figures in USD.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | May 2017 | May 2018 | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.25M | -4.14M | -4.88M | -310.00K | -607.00K | -2.26M | -6.28M | -4.50M | -1.35M | -5.64M | -2.02M | -2.70M | - | 10.01M | 1.76M | -7.40M | -3.31M |
| Investing Cash Flow | -69.00K | -15.00K | 1.33M | -127.00K | -289.00K | -118.00K | -919.00K | -477.00K | -572.00K | -173.00K | -163.00K | -227.00K | - | -18.66M | 17.25M | -16.07M | -3.87M |
| Financing Cash Flow | 176.00K | 343.00K | 1.58M | 1.06M | 391.00K | 6.41M | 2.51M | 21.84M | 925.00K | -5.55M | 2.17M | 1.96M | - | 7.32M | 139.00K | 625.00K | 97.21M |
| Capital Expenditure | -69.00K | -15.00K | -45.00K | -127.00K | -339.00K | -118.00K | -919.00K | -477.00K | -572.00K | -173.00K | -163.00K | -227.00K | - | -1.36M | -749.00K | -4.99M | -2.07M |
| Free Cash Flow | 3.18M | -4.16M | -4.92M | -437.00K | -946.00K | -2.37M | -7.20M | -4.97M | -1.92M | -5.81M | -2.19M | -2.93M | - | 8.65M | 1.01M | -12.39M | -5.38M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.32M | 19.15M | -22.84M | 90.03M |
Ratios (Annual)
Figures in %.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | May 2017 | May 2018 | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 52.3% | 40.1% | 40.0% | 41.1% | 51.9% | 38.3% | 35.5% | 35.9% | 41.9% | 36.1% | 37.6% | 36.3% | - | 50.4% | 49.1% | 40.6% | 35.3% |
| Operating Margin % | -6.5% | -30.5% | -29.0% | -20.1% | 2.5% | -66.8% | -42.4% | -26.1% | 3.1% | -23.7% | -12.4% | -25.2% | - | 20.6% | 15.2% | -8.2% | -28.3% |
| Net Margin % | -4.1% | -24.7% | -21.8% | -20.7% | 2.1% | -66.4% | -46.8% | -29.9% | 1.8% | -24.9% | -12.6% | -12.2% | - | 22.4% | 50.1% | -6.6% | -14.3% |
| ROE % | -4.3% | -37.2% | -52.3% | -68.2% | 6.0% | -145.5% | 965.1% | -33.6% | 2.7% | -33.8% | -19.9% | -17.7% | - | 19.3% | 29.7% | -3.2% | -3.2% |
| ROCE % | - | -43.9% | -66.2% | -62.7% | 7.0% | -80.2% | -114.7% | -21.4% | 4.6% | -31.7% | -16.5% | -33.2% | - | 16.3% | 8.6% | -3.6% | -6.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.15% | 2.66M | $214.92M |
| 2 | Vanguard Capital Management LLC | 4.05% | 1.32M | $106.70M |
| 3 | Shaw D.E. & Co., Inc. | 3.61% | 1.18M | $95.15M |
| 4 | Two Sigma Investments, LP | 3.57% | 1.16M | $94.11M |
| 5 | FMR, LLC | 3.09% | 1.01M | $81.36M |
| 6 | Vanguard Portfolio Management LLC | 2.96% | 966.66K | $78.12M |
| 7 | Geode Capital Management, LLC | 2.68% | 875.50K | $70.75M |
| 8 | Goldman Sachs Group Inc | 2.48% | 810.04K | $65.46M |
| 9 | Jane Street Group, LLC | 2.31% | 753.52K | $60.89M |
| 10 | JPMORGAN CHASE & CO | 2.25% | 732.55K | $59.20M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AEHR
Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?
Aehr's AI testing business gains momentum with major orders, new customer opportunities and a path toward recurring revenues.
Are Computer and Technology Stocks Lagging Aehr Test Systems (AEHR) This Year?
Here is how Aehr Test Systems (AEHR) and Fortinet (FTNT) have performed compared to their sector so far this year.
Aehr Test Systems (AEHR) Climbs 13%; Hedge Fund Holdings Rocket by Eightfold
Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week. According to the company, Chief Executive Officer Gayn Erickson and Ch…
Aehr Test Systems to Participate in the 10th Annual Lake Street Capital Markets Best Ideas Growth Conference on September 10
"We look forward to discussing with investors and shareholders Aehr's expanding role in enabling the next generation of semiconductor devices across a wide range of markets," said Mr. "Aehr delivers complete turnkey solutions that improve t…
William Blair Says These Stocks Are Must-Own Picks
William Blair Names 8 New Stock Picks: AI, Defense and Healthcare Stand Out
Is Aehr Test Systems (AEHR) Trading At A Premium For Too Long?
Aehr Test Systems stock has logged a very strong run over the past few years, yet the current valuation screens as expensive on broader checks. Recent pullbacks sit against a long multi year gain, which leaves investors weighing how much of…
AEHR — Frequently Asked Questions
What is the current share price of Aehr Test Systems, Inc. (AEHR)?
As of 2026-09-07 16:24 PDT, Aehr Test Systems, Inc. (AEHR) trades at $86.26 on NasdaqCM. Its 52-week range is $17.38 to $145.61.
What is the market capitalisation of AEHR?
Aehr Test Systems, Inc. (AEHR) has a market capitalisation of $2.81B on NasdaqCM.
What is the P/E ratio of AEHR?
AEHR trades at a trailing price-to-earnings (P/E) ratio of -375.04. The industry average P/E is 32.42. Its price-to-book (P/B) ratio is 15.25.
What is the return on equity (ROE) of AEHR?
AEHR has a return on equity (ROE) of -4.16%. Its return on capital employed (ROCE) is -6.18%.
Is AEHR a good stock to buy?
This page provides a data-driven analysis of Aehr Test Systems, Inc. (AEHR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.